Respiratory and Urinary Tract Infections, Arthritis, and Asthma Associated with HTLV-I and HTLV-II Infection
Edward L. Murphy*, Baoguang Wang†, Ronald A. Sacher‡, Joy Fridey§, James W. Smith¶, Catharie C. Nass#, Bruce Newman**, Helen E. Ownby**, George Garratty††, Sheila T. Hutching††, and George B. Schreiber†
Author affiliations: *University of California San Francisco, California, USA; †Westat, Rockville, Maryland, USA; ‡Hoxworth Blood Center, Cincinnati, Ohio, USA; §Blood Bank of San Bernardino and Riverside Counties, San Bernardino, California, USA; ¶Oklahoma Blood Institute, Oklahoma City, Oklahoma, USA; #American Red Cross Blood Services Chesapeake and Potomac, Baltimore, Maryland, USA; **American Red Cross Blood Services Southeastern Michigan, Detroit, Michigan, USA; ††American Red Cross Blood Services Southern California, Los Angeles, California, USA
Figure. Kaplan-Meier survival curves showing disease-free survival for one noninfectious and three infectious diseases, by human T-lymphotropic virus (HTLV) status, through visits 2 and 3 of prospective observation. HTLV-I–infected (triangles) and HTLV-II–infected (squares) participants are compared to HLTV-seronegative participants (diamonds), respectively. Panels are as follows: A) pneumonia; B) acute bronchitis; C) bladder or kidney infection; and D) hypertension. The vertical axis scale has been compressed because of the lower overall incidence of pneumonia.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.